Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashley Perry

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Cancer Survivorship : Research and Practice|April 26, 2023
Implementation of a Cancer Rehabilitation Navigation Program: a qualitative analysis of implementation determinants and strategiesNicole L Stout, Shana E Harrington, Ashley Perry, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Does Molecular Profiling of <i>KRAS</i>-Mutant Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Help in Treatment Strategy Planning?Nagla Abdel Karim, Asad Ullah, Peterson Pathrose, et al.
Journal of Clinical Medicine|May 25, 2024
Incidence of Thrombosis in COVID-19 Patients Compared to Non-COVID-19 Sepsis Patients in the Intensive Care UnitSherri Huang, Ashley Perry, Carlos Sanchez Parra, et al.
The International Journal on Drug Policy|December 13, 2021
Factors associated with opioid-involved overdose among previously incarcerated people in the U.S.: A community engaged narrative reviewJuliet M Flam-Ross, Josh Lown, Prasad Patil, et al.
The Oncologist|April 25, 2014
Isocitrate dehydrogenase 1 (IDH1) mutation in breast adenocarcinoma is associated with elevated levels of serum and urine 2-hydroxyglutarateAmir T Fathi, Hossein Sadrzadeh, Amy H Comander, et al.
Cancer|November 14, 2018
Isocitrate dehydrogenase 1 and 2 mutations, 2-hydroxyglutarate levels, and response to standard chemotherapy for patients with newly diagnosed acute myeloid leukemiaAndrew M Brunner, Donna S Neuberg, Seth A Wander, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Cancer Survivorship : Research and Practice|April 26, 2023
Implementation of a Cancer Rehabilitation Navigation Program: a qualitative analysis of implementation determinants and strategiesNicole L Stout, Shana E Harrington, Ashley Perry, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Does Molecular Profiling of <i>KRAS</i>-Mutant Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Help in Treatment Strategy Planning?Nagla Abdel Karim, Asad Ullah, Peterson Pathrose, et al.
Journal of Clinical Medicine|May 25, 2024
Incidence of Thrombosis in COVID-19 Patients Compared to Non-COVID-19 Sepsis Patients in the Intensive Care UnitSherri Huang, Ashley Perry, Carlos Sanchez Parra, et al.
The International Journal on Drug Policy|December 13, 2021
Factors associated with opioid-involved overdose among previously incarcerated people in the U.S.: A community engaged narrative reviewJuliet M Flam-Ross, Josh Lown, Prasad Patil, et al.
The Oncologist|April 25, 2014
Isocitrate dehydrogenase 1 (IDH1) mutation in breast adenocarcinoma is associated with elevated levels of serum and urine 2-hydroxyglutarateAmir T Fathi, Hossein Sadrzadeh, Amy H Comander, et al.
Cancer|November 14, 2018
Isocitrate dehydrogenase 1 and 2 mutations, 2-hydroxyglutarate levels, and response to standard chemotherapy for patients with newly diagnosed acute myeloid leukemiaAndrew M Brunner, Donna S Neuberg, Seth A Wander, et al.
Pageof 2